A new study published in Ecology Letters has uncovered the mechanisms underlying plant community assembly and biodiversity ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
LAHORE: Artificial intelligence (AI) is enabling researchers to uncover new cancer applications for widely used medicines by ...
Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug discovery platform. Built on seven years of development and ...
AI Foundation Model for Tumor and Immune Biology to Guide Precision Patient Selection for Novel Bifunctional OTP-01 BostonGene, the developer of the leading AI foundation model for tumor and immune ...
Meta-analysis shows diabetes increases male infertility risk, with inflammation identified as a key underlying mechanism.
The maternal microbiome and immune system have both independent and synergistic effects on fetal brain health—changes in the ...
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
ZME Science on MSN
Meet Stephen Quake: The Scientist Who Treats Biology like Physics and Turned Life Into Data
Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.
Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback